MGMT-inhibitor in combination with TGF-βRI inhibitor or CDK 4/6 inhibitor increases temozolomide sensitivity in temozolomide-resistant glioblastoma cells
Titel:
MGMT-inhibitor in combination with TGF-βRI inhibitor or CDK 4/6 inhibitor increases temozolomide sensitivity in temozolomide-resistant glioblastoma cells
Auteur:
Das, A. Henderson, F. C. Alshareef, M. Porto, G. B. F. Kanginakudru, I. Infinger, L. K. Vandergrift, W. A. Lindhorst, S. M. Varma, A. K. Patel, S. J. Cachia, D.